Alpine Immune Sciences Inc (ALPN.OQ)
ALPN.OQ on NASDAQ Stock Exchange Global Market
4.63USD
22 Aug 2019
4.63USD
22 Aug 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$4.63
$4.63
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
2,632
2,632
52-wk High
$7.99
$7.99
52-wk Low
$3.46
$3.46
About
Alpine Immune Sciences, Inc., formerly Nivalis Therapeutics, Inc., is focused on developing a protein-based immunotherapies using Variant immunoglobulin domain (vlgD) platform technology. The vlgD platform is designed to interact with multiple targets, including many present in the immune synapse. The vlgDs are developed using a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $168.94 |
| Shares Outstanding(Mil.): | 13.88 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates